Management of Common Side Effects of Family Planning Methods

Post focus: Management of common contraceptive side effects — bleeding changes, amenorrhoea, nausea, headache, breast tenderness, mood/weight/acne changes, injection/implant and IUD problems, barrier reactions, red flags, counselling and switching.

Learning objectives

• Differentiate expected, tolerable effects from danger signs and unrelated disease.
• Use a systematic assessment before treatment or discontinuation.
• Manage common symptoms with reassurance, non-drug care and safe short courses of medicines.
• Know when to switch/remove a method, investigate, refer or provide emergency care.
• Communicate in a way that prevents misinformation and supports voluntary continuation.

1. The six-step side-effect consultation

1. Listen and validate: ask what changed, how severe it is and what the client fears.
2. Confirm method/exposure: name, start date, dose/interval, missed doses, insertion details and other medicines.
3. Rule out urgent causes: pregnancy/ectopic pregnancy, infection/PID, anaemia, hypertension, VTE, stroke, liver disease, malignancy, trauma or device perforation.
4. Examine/test selectively: vital signs/BP, pregnancy test, pelvic/speculum, STI tests, CBC, ultrasound or other tests as indicated.
5. Treat/support: non-drug measures, method-specific medicine or switch/remove if desired/unsafe.
6. Safety-net and follow-up: give written red flags, return date and a no-penalty option to change methods.

2. Bleeding changes

Spotting, irregular bleeding, lighter bleeding or amenorrhoea are common with implants, injectables, POPs and hormonal IUDs. COCs often stabilise bleeding, while copper IUDs may cause heavier/longer menses initially. Bleeding is not automatically harmful, but new heavy or painful bleeding needs assessment.

2.1 Assess

• Pregnancy test and ectopic symptoms (unilateral pain, syncope, shoulder-tip pain).
• Adherence/missed pills, late injections, emergency contraception or drug interactions.
• STI/PID symptoms, cervical lesion, fibroid, polyp, thyroid disease, coagulopathy and anaemia.
• Quantify pads/clots, duration, dizziness, pallor, pulse/BP and haemoglobin when clinically indicated.

2.2 Management

Do not give aspirin for heavy contraceptive bleeding because it can increase bleeding. Avoid empiric repeated antibiotics without evidence of infection.

3. Amenorrhoea

• Common and usually benign with DMPA, implants, POPs and hormonal IUD. Explain that blood is not “trapped” and amenorrhoea does not cause infertility.
• Perform a pregnancy test if late/missed doses, symptoms, no expected withdrawal bleed after COC or pregnancy risk. Assess breastfeeding, weight change, stress, thyroid disease and hyperprolactinaemia if persistent and unexplained.
• With DMPA, reassure after a negative test; no treatment is required unless distressing. If pregnancy is confirmed, stop unnecessary hormones and assess ectopic symptoms.
• Sudden amenorrhoea with severe headache/visual symptoms, galactorrhoea or neurologic signs requires evaluation.

4. Nausea and vomiting

• Common early with oestrogen-containing pills/emergency pills. Take with food or at bedtime; ensure hydration and consider switching to a lower-oestrogen/progestin-only method.
• If vomiting occurs within the product’s absorption window, follow the specific pack/emergency-contraception instruction for repeat dose and use backup.
• Persistent vomiting, dehydration, severe abdominal pain or pregnancy concern requires examination; do not assume it is contraception.
• Short antiemetic use may be considered by a clinician after checking pregnancy, QT risk and interactions.

5. Headache and migraine

• Check onset, severity, BP, fever, neurologic signs and relation to the method. Mild tension headache may respond to paracetamol 500–1000 mg orally every 6–8 hours (maximum 4 g/day in healthy adults; lower with liver disease/alcohol) or ibuprofen if safe.
• New migraine with aura, focal neurologic deficit, thunderclap headache, severe hypertension, visual/speech disturbance or meningism is an emergency; stop oestrogen pending assessment and refer.
• Recurrent migraine with aura generally contraindicates combined oestrogen methods; offer progestin-only/non-hormonal alternatives under MEC.

6. Breast tenderness

• Check pregnancy, breastfeeding, trauma, infection, mass or nipple discharge; examine if persistent/unilateral.
• Supportive bra, warm/cool compresses, reassurance and paracetamol/ibuprofen if safe. Consider method switch if severe and persistent.
• Refer a hard fixed mass, bloody discharge, skin/nipple retraction, fever or abscess.

7. Mood change, depression and libido

Ask about timing, sleep, relationships, violence, substance use and prior mood disorder. Screen directly for self-harm/suicide; an urgent safety pathway overrides routine side-effect management. Provide supportive counselling, mental-health referral and consider switching methods collaboratively. Do not attribute every mood symptom to contraception or stop an effective method without discussing pregnancy risk.

8. Weight and appetite changes

• Measure baseline and follow-up weight only with consent; assess diet, activity, sleep, thyroid disease, pregnancy, oedema and medicines.
• DMPA is associated with variable weight gain in some users; discuss healthy local foods, activity and alternatives if unacceptable. Avoid stigma or unsafe dieting.
• Rapid unexplained weight loss, oedema, severe fatigue or eating-disorder signs require medical evaluation.

9. Acne, skin and hair changes

• Progestin sensitivity may worsen acne; some combined methods improve it. Assess severity, scarring and pregnancy before treatment.
• Gentle cleanser, non-comedogenic products and topical benzoyl peroxide/adapalene under local guidance; avoid teratogenic retinoids in pregnancy.
• Sudden hirsutism/virilisation, severe rash, facial swelling or jaundice requires evaluation for allergy/systemic disease.

10. IUD-related problems

10.1 Cramping and pain

Mild cramps after insertion are common; NSAIDs (e.g., ibuprofen 400 mg TID with food for up to 5 days if safe) and heat may help. Severe/worsening pain, fever, offensive discharge, cervical motion tenderness or pregnancy requires urgent evaluation for PID, perforation or ectopic pregnancy.

10.2 Strings not felt or changed

Exclude pregnancy, use backup contraception and arrange examination/ultrasound. Do not attempt blind removal. Missing strings can be retracted, expelled or perforated.

10.3 Expulsion

Heavy bleeding, cramping or feeling plastic in the vagina may indicate expulsion. Do not push it back; use condoms/EC as indicated and arrange prompt review/reinsertion or alternative method.

10.4 Infection

PID risk is mainly around insertion when an undiagnosed STI is present. Test/treat promptly; the IUD does not always need removal, but remove if no improvement or if the client requests after counselling.

11. Implant-related problems

• Irregular bleeding: reassure, rule out pregnancy/STI and use short NSAID/COC only when eligible.
• Bruising/swelling: pressure, cold pack and review; infection signs need examination/antibiotics if indicated.
• Rod cannot be felt, deep pain, numbness or migration: do not cut blindly; use imaging and trained removal.
• Pregnancy with implant, especially pain/bleeding: urgent pregnancy-location assessment because ectopic pregnancy must be excluded.

12. Injectable-specific concerns

• Late injection: pregnancy test/timing assessment, give injection when eligible, use backup and consider EC after unprotected sex.
• Delayed fertility return after DMPA is expected; counsel before initiation and evaluate infertility only after appropriate time off method.
• Bone health: assess fracture risk, nutrition, exercise and prolonged use; do not perform routine bone-density testing unless other risk factors.
• Severe depression, jaundice, pregnancy, unexplained bleeding or serious allergy requires review before the next dose.

13. Barrier-method and natural-method problems

• Latex irritation/allergy: stop latex, use non-latex condom; facial swelling/wheeze is anaphylaxis.
• Diaphragm/cap discomfort, recurrent UTI or offensive discharge: remove, examine, check fit and infection, and consider another method.
• Spermicide irritation: stop nonoxynol-9, especially with high HIV exposure; provide condoms/alternative.
• Fertility-awareness anxiety or unintended pregnancy: review teaching/partner cooperation and offer EC or a more effective method without blame.

14. Red flags: urgent referral

15. Counselling messages that prevent discontinuation

• Explain expected timing and severity before initiation; clients who know what to expect are more likely to continue safely.
• Distinguish “common and not dangerous” from “uncommon and urgent.” Never dismiss pain or bleeding.
• Offer treatment, method switch or removal at the client’s request; no method is mandatory.
• Reinforce return to fertility, STI protection with condoms, adherence and follow-up.
• Use simple written instructions and teach-back, considering literacy, language, disability and privacy.

16. Worked cases

Case 1: prolonged implant bleeding

Check pregnancy, adherence/interactions, STI symptoms and anaemia. If stable and tests are reassuring, explain expected bleeding, offer a short NSAID course if safe and discuss a short COC or switching. Return urgently for haemodynamic symptoms.

Case 2: heavy bleeding with copper IUD

Assess pregnancy/ectopic symptoms, PID, anaemia and structural disease. Use an NSAID during menses when safe, consider specialist tranexamic acid/local protocol, and discuss LNG-IUD or other method if bleeding remains unacceptable.

Case 3: headache on combined pill

Characterise aura/neurologic symptoms and measure BP. New aura or focal deficit means stop oestrogen and refer urgently; uncomplicated tension headache can be treated symptomatically while reviewing method choice.

17. Quick self-test

1. What must be excluded before reassuring a client about new irregular bleeding?
2. Name three ACHES/VTE or neurologic danger symptoms.
3. Which contraceptive commonly causes delayed fertility return?
4. What should a client do if IUD strings cannot be felt?
5. Why should aspirin generally be avoided for contraceptive heavy bleeding?

Further study and source material

• Slideshare: The side effects of contraceptives.
• WHO Family Planning Global Handbook for Providers.
• WHO Medical Eligibility Criteria.
• WHO contraception overview.
• Uganda reproductive-health policy and service standards.

Take-home: Side-effect care begins with listening and ruling out danger. Reassure expected effects, treat symptoms safely, investigate red flags, offer a switch or removal without judgement, and always protect against pregnancy and STIs during transitions.